Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bardet-Biedl Syndrome | 8 | 2025 | 8 | 3.910 |
Why?
|
| Hyperphagia | 5 | 2025 | 15 | 2.160 |
Why?
|
| Receptor, Melanocortin, Type 4 | 2 | 2025 | 9 | 1.170 |
Why?
|
| Weight Gain | 7 | 2025 | 138 | 0.870 |
Why?
|
| Psychometrics | 1 | 2025 | 350 | 0.800 |
Why?
|
| Child | 12 | 2025 | 3381 | 0.650 |
Why?
|
| Exercise | 8 | 2021 | 674 | 0.570 |
Why?
|
| Obesity | 10 | 2024 | 1131 | 0.560 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 532 | 0.520 |
Why?
|
| Child, Preschool | 9 | 2025 | 1516 | 0.490 |
Why?
|
| Body Composition | 6 | 2024 | 160 | 0.480 |
Why?
|
| Life Style | 5 | 2021 | 326 | 0.410 |
Why?
|
| Adult | 20 | 2025 | 13458 | 0.410 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2022 | 39 | 0.380 |
Why?
|
| Humans | 30 | 2025 | 42163 | 0.360 |
Why?
|
| Female | 24 | 2025 | 24018 | 0.350 |
Why?
|
| Adolescent | 7 | 2025 | 5950 | 0.350 |
Why?
|
| Diet | 4 | 2017 | 810 | 0.340 |
Why?
|
| Registries | 2 | 2025 | 431 | 0.340 |
Why?
|
| Infant | 7 | 2025 | 1143 | 0.330 |
Why?
|
| Sleep | 3 | 2021 | 179 | 0.320 |
Why?
|
| Cross-Sectional Studies | 9 | 2025 | 3077 | 0.310 |
Why?
|
| Male | 17 | 2025 | 22779 | 0.300 |
Why?
|
| Body Mass Index | 8 | 2020 | 916 | 0.290 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 729 | 0.270 |
Why?
|
| Pregnancy Complications | 2 | 2021 | 134 | 0.260 |
Why?
|
| Physical Fitness | 2 | 2017 | 93 | 0.250 |
Why?
|
| Nevus, Pigmented | 1 | 2025 | 6 | 0.240 |
Why?
|
| Health Promotion | 2 | 2025 | 691 | 0.230 |
Why?
|
| Pregnancy | 7 | 2025 | 1737 | 0.220 |
Why?
|
| Cost of Illness | 1 | 2025 | 95 | 0.220 |
Why?
|
| alpha-MSH | 1 | 2024 | 5 | 0.220 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 1020 | 0.220 |
Why?
|
| Chaperonins | 2 | 2022 | 5 | 0.220 |
Why?
|
| Infant, Newborn | 3 | 2025 | 960 | 0.220 |
Why?
|
| Quality of Life | 2 | 2025 | 599 | 0.200 |
Why?
|
| Caregivers | 1 | 2025 | 195 | 0.200 |
Why?
|
| Body Weight | 2 | 2024 | 428 | 0.190 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2021 | 4 | 0.190 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 19 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 744 | 0.180 |
Why?
|
| Insulin Resistance | 1 | 2022 | 199 | 0.170 |
Why?
|
| Young Adult | 3 | 2025 | 4936 | 0.160 |
Why?
|
| Body Height | 1 | 2020 | 53 | 0.160 |
Why?
|
| Genetic Markers | 1 | 2020 | 146 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 95 | 0.160 |
Why?
|
| Vitamin D | 1 | 2021 | 196 | 0.160 |
Why?
|
| Age Factors | 2 | 2020 | 1139 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2021 | 1729 | 0.150 |
Why?
|
| Sex Factors | 2 | 2020 | 1008 | 0.150 |
Why?
|
| Feeding Behavior | 3 | 2020 | 461 | 0.150 |
Why?
|
| Energy Intake | 1 | 2019 | 162 | 0.140 |
Why?
|
| Overweight | 2 | 2021 | 248 | 0.140 |
Why?
|
| Genotype | 1 | 2020 | 796 | 0.140 |
Why?
|
| Phenotype | 1 | 2020 | 774 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 38 | 0.130 |
Why?
|
| Sweden | 4 | 2017 | 17 | 0.130 |
Why?
|
| Parents | 2 | 2017 | 359 | 0.130 |
Why?
|
| Leisure Activities | 1 | 2016 | 38 | 0.130 |
Why?
|
| Bone Development | 1 | 2016 | 28 | 0.130 |
Why?
|
| Muscle Development | 1 | 2016 | 51 | 0.120 |
Why?
|
| Self Efficacy | 1 | 2017 | 211 | 0.120 |
Why?
|
| Habits | 1 | 2015 | 8 | 0.120 |
Why?
|
| Prevalence | 1 | 2020 | 1597 | 0.120 |
Why?
|
| Exercise Tolerance | 1 | 2015 | 22 | 0.120 |
Why?
|
| Acculturation | 1 | 2017 | 203 | 0.120 |
Why?
|
| Child Development | 1 | 2016 | 95 | 0.120 |
Why?
|
| Primary Prevention | 1 | 2015 | 63 | 0.120 |
Why?
|
| Diet Records | 1 | 2015 | 58 | 0.120 |
Why?
|
| Adiposity | 1 | 2016 | 155 | 0.110 |
Why?
|
| Mexican Americans | 1 | 2017 | 224 | 0.110 |
Why?
|
| Middle Aged | 4 | 2025 | 11819 | 0.110 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 72 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2015 | 83 | 0.110 |
Why?
|
| Counseling | 1 | 2015 | 134 | 0.110 |
Why?
|
| Risk Factors | 2 | 2020 | 3942 | 0.110 |
Why?
|
| Maternal-Fetal Relations | 1 | 2014 | 1 | 0.110 |
Why?
|
| Adipokines | 1 | 2014 | 25 | 0.110 |
Why?
|
| Birth Weight | 1 | 2014 | 94 | 0.100 |
Why?
|
| Telemedicine | 1 | 2017 | 215 | 0.100 |
Why?
|
| Insulin | 2 | 2014 | 255 | 0.100 |
Why?
|
| Motor Activity | 1 | 2015 | 438 | 0.100 |
Why?
|
| Health Behavior | 1 | 2016 | 568 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2017 | 705 | 0.090 |
Why?
|
| Blood Glucose | 3 | 2021 | 386 | 0.080 |
Why?
|
| Puerto Rico | 2 | 2025 | 1376 | 0.070 |
Why?
|
| Poverty | 2 | 2025 | 395 | 0.070 |
Why?
|
| Muscle Strength | 2 | 2017 | 36 | 0.060 |
Why?
|
| Alaska | 2 | 2017 | 61 | 0.060 |
Why?
|
| Postpartum Period | 2 | 2017 | 91 | 0.060 |
Why?
|
| Hunger | 1 | 2024 | 12 | 0.060 |
Why?
|
| Waist Circumference | 1 | 2024 | 90 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 1051 | 0.050 |
Why?
|
| Weight Loss | 1 | 2024 | 138 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2025 | 175 | 0.050 |
Why?
|
| Time Factors | 2 | 2019 | 1848 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 36 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2016 | 487 | 0.050 |
Why?
|
| Mothers | 1 | 2025 | 212 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 99 | 0.050 |
Why?
|
| Penetrance | 1 | 2022 | 6 | 0.050 |
Why?
|
| Triglycerides | 1 | 2022 | 146 | 0.050 |
Why?
|
| Fishes | 1 | 2022 | 59 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 109 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 107 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 242 | 0.040 |
Why?
|
| Walking | 1 | 2021 | 85 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2024 | 1586 | 0.040 |
Why?
|
| Seasons | 1 | 2019 | 133 | 0.040 |
Why?
|
| Aged | 3 | 2016 | 7982 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 358 | 0.040 |
Why?
|
| Cytokines | 1 | 2022 | 661 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 45 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2021 | 359 | 0.030 |
Why?
|
| Motor Skills | 1 | 2017 | 45 | 0.030 |
Why?
|
| Mutation | 1 | 2022 | 1169 | 0.030 |
Why?
|
| Plethysmography, Whole Body | 1 | 2016 | 1 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 729 | 0.030 |
Why?
|
| Income | 1 | 2017 | 160 | 0.030 |
Why?
|
| Mexico | 1 | 2017 | 286 | 0.030 |
Why?
|
| Child Behavior | 1 | 2016 | 81 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2017 | 180 | 0.030 |
Why?
|
| United States | 2 | 2017 | 5072 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 263 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 662 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 224 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 249 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 311 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 638 | 0.030 |
Why?
|
| Adiponectin | 1 | 2014 | 59 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2014 | 165 | 0.030 |
Why?
|
| Leptin | 1 | 2014 | 118 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1054 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 845 | 0.020 |
Why?
|
| Monitoring, Ambulatory | 1 | 2011 | 14 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 28 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 76 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2011 | 181 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 261 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1574 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 16695 | 0.010 |
Why?
|